Secora Michael insider trades
Secora Michael has filed 30 Form 4s with the SEC that we hold, all for Recursion Pharmaceuticals, INC. (RXRX), as Chief Financial Officer. Across all of them we count 0 purchases worth $0 and 39 sales worth $6.4M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 24,500 shares of Recursion Pharmaceuticals, INC. worth $333.7K, dated 2023-07-18. The first filing on our record is dated 2022-02-08 and the latest 2024-11-19.
Recursion Pharmaceuticals, INC. (RXRX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-06-13 | S, sale reported on Form 4 | 25,000 | $248.2K | 2023-06-15 |
| 2023-06-14 | S, sale reported on Form 4 | 25,000 | $251.8K | 2023-06-15 |
| 2023-07-18 | S, sale reported on Form 4 | 500 | $7.0K | 2023-07-19 |
| 2023-07-18 | S, sale reported on Form 4 | 24,500 | $333.7K | 2023-07-19 |
| 2023-07-19 | S, sale reported on Form 4 | 1,991 | $28.6K | 2023-07-19 |
| 2023-07-19 | S, sale reported on Form 4 | 13,150 | $202.0K | 2023-07-19 |
| 2023-07-19 | S, sale reported on Form 4 | 9,859 | $157.7K | 2023-07-19 |
| 2023-08-15 | S, sale reported on Form 4 | 25,000 | $231.8K | 2023-08-17 |
| 2023-08-16 | S, sale reported on Form 4 | 25,000 | $222.5K | 2023-08-17 |
| 2023-09-12 | S, sale reported on Form 4 | 25,000 | $210.8K | 2023-09-14 |
| 2023-09-13 | S, sale reported on Form 4 | 25,000 | $217.2K | 2023-09-14 |
| 2023-10-10 | S, sale reported on Form 4 | 25,000 | $176.8K | 2023-10-12 |
| 2023-10-11 | S, sale reported on Form 4 | 25,000 | $171.2K | 2023-10-12 |
| 2023-11-14 | S, sale reported on Form 4 | 25,000 | $158.0K | 2023-11-16 |
| 2023-11-15 | S, sale reported on Form 4 | 20,300 | $147.2K | 2023-11-16 |
| 2023-11-15 | S, sale reported on Form 4 | 4,700 | $35.8K | 2023-11-16 |
| 2023-12-12 | S, sale reported on Form 4 | 25,000 | $184.8K | 2023-12-14 |
| 2023-12-13 | S, sale reported on Form 4 | 25,000 | $189.8K | 2023-12-14 |
| 2024-01-16 | S, sale reported on Form 4 | 25,000 | $261.2K | 2024-01-18 |
| 2024-01-17 | S, sale reported on Form 4 | 25,000 | $256.2K | 2024-01-18 |
| 2024-02-13 | S, sale reported on Form 4 | 25,000 | $246.5K | 2024-02-15 |
| 2024-02-14 | S, sale reported on Form 4 | 23,933 | $249.6K | 2024-02-15 |
| 2024-02-14 | S, sale reported on Form 4 | 1,067 | $11.7K | 2024-02-15 |
| 2024-03-12 | S, sale reported on Form 4 | 25,000 | $261.5K | 2024-03-14 |
| 2024-03-13 | S, sale reported on Form 4 | 25,000 | $275.8K | 2024-03-14 |
| 2024-04-16 | S, sale reported on Form 4 | 25,000 | $191.8K | 2024-04-18 |
| 2024-04-17 | S, sale reported on Form 4 | 23,124 | $175.3K | 2024-04-18 |
| 2024-06-13 | S, sale reported on Form 4 | 15,000 | $139.8K | 2024-06-17 |
| 2024-06-14 | S, sale reported on Form 4 | 15,000 | $139.1K | 2024-06-17 |
| 2024-07-09 | S, sale reported on Form 4 | 15,000 | $109.8K | 2024-07-11 |
| 2024-07-10 | S, sale reported on Form 4 | 15,000 | $108.6K | 2024-07-11 |
| 2024-08-13 | S, sale reported on Form 4 | 15,000 | $95.2K | 2024-08-15 |
| 2024-08-14 | S, sale reported on Form 4 | 15,000 | $95.2K | 2024-08-15 |
| 2024-09-10 | S, sale reported on Form 4 | 15,000 | $92.5K | 2024-09-12 |
| 2024-09-11 | S, sale reported on Form 4 | 15,000 | $94.8K | 2024-09-12 |
| 2024-10-08 | S, sale reported on Form 4 | 15,000 | $94.8K | 2024-10-10 |
| 2024-10-09 | S, sale reported on Form 4 | 15,000 | $95.4K | 2024-10-10 |
| 2024-11-12 | S, sale reported on Form 4 | 15,000 | $114.6K | 2024-11-14 |
| 2024-11-13 | S, sale reported on Form 4 | 15,000 | $114.9K | 2024-11-14 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1855980) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms